日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Treatment Patterns of Pancreatic Neuroendocrine Tumor (pNET) Patients at Two Canadian Cancer Centres

加拿大两家癌症中心胰腺神经内分泌肿瘤(pNET)患者的治疗模式

Nair, Gautham; Black, Morgan; Baer, Kathie; Welch, Stephen; Laidley, David T; Goodwin, Rachel; Leung, Macyn; Phillips, William J; Vickers, Michael; Asmis, Tim; Marginean, Horia; Tsvetkova, Elena

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2024

2024年加拿大东部胃肠道癌症共识会议

Leigh, Jennifer; Ahmed, Arwa; Aubin, Francine; Berry, Scott; Boucher, Melanie; Campeau, Marie-Pierre; Colwell, Bruce; Connors, Stacie; Corbett, Jessica; Dadwal, Shivani; Dudani, Shaan; Elimova, Elena; Falkson, Conrad; Galvis, Luisa; Goel, Rakesh; Gotfrit, Joanna; Hyde, Angela; Febbraro, Michela; Laidley, David T; Locke, Gordon; Mahmud, Aamer; Baccili Cury Megid, Thais; Michael, James; Nair, Vimoj J; Quigley, Stephen; Ramjeesingh, Ravi; Samimi, Setareh; Seal, Melanie; Snow, Stephanie; Spadafora, Silvana; Stuckless, Teri; Wilson, Brooke; Asmis, Timothy; Goodwin, Rachel; Vickers, Michael

TTK/MPS1 inhibitor OSU-13 targets the mitotic checkpoint and is a potential therapeutic strategy for myeloma

TTK/MPS1抑制剂OSU-13靶向有丝分裂检查点,是治疗多发性骨髓瘤的潜在策略。

Longo, Larissa Valle Guilhen; Hughes, Tiffany; McNeil-Laidley, Betina; Cottini, Francesca; Hilinski, Gerard; Merritt, Elizabeth; Benson, Don M

(177)Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: A Review of the Evidence and Implications for Canadian Clinical Practice

(177)Lu-PSMA-617 在转移性去势抵抗性前列腺癌中的应用:证据综述及其对加拿大临床实践的意义

Chi, Kim N; Yip, Steven M; Bauman, Glenn; Probst, Stephan; Emmenegger, Urban; Kollmannsberger, Christian K; Martineau, Patrick; Niazi, Tamim; Pouliot, Frédéric; Rendon, Ricardo; Hotte, Sebastien J; Laidley, David T; Saad, Fred

Clinical Outcome Patterns of Use of Radium-223 in Patients with Metastatic Castration-Resistant Prostate Cancer

镭-223在转移性去势抵抗性前列腺癌患者中的临床疗效模式

Mackenzie, Colleen; Deluce, Jasna; Black, Morgan; Churchman, Emma; Winquist, Eric; Ernst, Scott; Laidley, David T; Parezanovic, Matthew; Potvin, Kylea; Fernandes, Ricardo

The use of Lutetium-177 PSMA radioligand therapy with high dose rate brachytherapy for locally recurrent prostate cancer after previous definitive radiation therapy: a randomized, single-institution, phase I/II study (ROADSTER)

采用镥-177 PSMA 放射性配体疗法联合高剂量率近距离放射疗法治疗既往根治性放射治疗后局部复发的前列腺癌:一项随机、单中心、I/II 期研究 (ROADSTER)

Mendez, Lucas C; Dhar, Aneesh; Laidley, David; Moussa, Madeleine; Gomez, Jose A; Chin, Joseph; Lee, T-Y; Thiessen, Jonathan D; Hoover, Douglas; Surrey, Kathleen; Helou, Joelle; Velker, Vikram; Correa, Rohann J; D'Souza, David; Bayani, Jane; Bauman, Glenn

Validation of the Foot and Ankle Outcome Score for Use in Infracalcaneal Heel Pain

验证足踝功能评分在跟骨下疼痛中的应用

Joshi, Alisha; Collazo, Christopher; Laidley, Zachary; Klein, Erin E; Weil, Lowell Jr; Sorensen, Matthew D; Fleischer, Adam E

Imaging Biomarkers in Prostate Stereotactic Body Radiotherapy: A Review and Clinical Trial Protocol

前列腺立体定向放射治疗中的影像学生物标志物:综述和临床试验方案

Liu, Wei; Loblaw, Andrew; Laidley, David; Fakir, Hatim; Mendez, Lucas; Davidson, Melanie; Kassam, Zahra; Lee, Ting-Yim; Ward, Aaron; Thiessen, Jonathan; Bayani, Jane; Conyngham, John; Bailey, Laura; Andrews, Joseph D; Bauman, Glenn

Survival predictors of (177)Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS)

(177)Lu-Dotatate肽受体放射性核素治疗(PRRT)在进展性高分化神经内分泌肿瘤(NETS)患者中的生存预测

Swiha, Mina M; Sutherland, Duncan E K; Sistani, Golmehr; Khatami, Alireza; Abazid, Rami M; Mujoomdar, Amol; Wiseman, Daniele P; Romsa, Jonathan G; Reid, Robert H; Laidley, David T

Mortality and Obesity Among U.S. Older Adults: The Role of Polygenic Risk

美国老年人的死亡率和肥胖:多基因风险的作用

Vinneau, Justin M; Huibregtse, Brooke M; Laidley, Thomas M; Goode, Joshua A; Boardman, Jason D